Target intelligence / Profile preview

Keratin, type I cuticular Ha2 (KRT32)

Target
KRT32
Molecular classification
Intermediate filament protein, Structural protein, Keratin family, type I acidic hair keratin
01

Overview

Keratin 32 (KRT32) is an acidic type I hair keratin, part of the intermediate filament protein family, predominantly expressed in the cuticular and basal layers of hair follicles and specific epithelial tissues such as skin and esophagus. KRT32 heterodimerizes with type II keratins to form the structural matrix of hair and nails. Beyond its structural role, KRT32 modulates keratinocyte behavior and skin immune responses, notably suppressing cell proliferation and inhibiting NF-κB signaling by promoting NEMO degradation. Damaging mutations in KRT32 lead to loss of anti-inflammatory function and excessive proliferation in keratinocytes, contributing to inflammatory skin disorders such as Pityriasis Rubra Pilaris. KRT32 is not currently targeted by approved drugs but emerging data support its potential relevance as a therapeutic or diagnostic target in inflammatory and proliferative skin conditions.

Other names
Ha-2Hair keratin, type I Ha2Keratin-32hard keratin type IHA2HKA2KRTHA2hHa2K32HHA2hair keratin, type I Ha2hard keratin, type I, 2keratin, hair, acidic, 2type I cuticular hair keratinKRT32
02

Mechanism of action

mechanistic studies show protein antagonizes NF-κB pathway via NEMO ubiquitination

03

Biological functions

Structural integrity of hair and nailsKeratinocyte differentiation and hair fibre formationSuppression of keratinocyte proliferationRegulation of skin immune homeostasis (via NF-κB pathway inhibition)
04

Disease associations

Pityriasis Rubra Pilaris (PRP), a skin disorderProstate squamous cell carcinoma (association)Schwannomatosis 1 (association)
05

Biomarkers

Potential biomarker for PRP disease susceptibility and severity (variant screening)

Beyond the preview

Go deeper on Keratin, type I cuticular Ha2 (KRT32).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin, type I cuticular Ha2 (KRT32).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call